Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit-Reference-Cited by-同舟云学术

Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit

Published:2017-04-22 Issue:3 Volume:30 Page:378-380
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Montaudié Henri¹²^ORCID,Cerezo Michael³,Bahadoran Philippe¹⁴,Roger Coralie⁵,Passeron Thierry¹²,Machet Laurent⁶,Arnault Jean-Philippe⁷,Verneuil Laurence⁸,Maubec Eve⁹,Aubin François¹⁰,Granel Florence¹¹,Giacchero Damien¹²,Hofman Véronique¹³¹⁴,Lacour Jean-Philippe¹,Maryline Allegra³,Ballotti Robert³,Rocchi Stéphane³

Affiliation:

1. Department of Dermatology; University Hospital of Nice; Nice France

2. Team 12; Centre Méditerranéen de Médecine Moléculaire; INSERM, U1065; Nice France

3. Team 1; Centre Méditerranéen de Médecine Moléculaire; INSERM, U1065; Nice France

4. Department of Dermatology; Clinical Research Center; Archet Hospital Nice France

5. Department of Clinical Research and Innovation; University Hospital of Nice; Nice France

6. Department of Dermatology; CHRU de Tours; University Francois Rabelais of Tours; Tours France

7. Department of Dermatology; University Hospital of Amiens; Amiens France

8. Department of Dermatology; University Hospital of Caen; Caen France

9. Department of Dermatology; University Hospital of Paris; Hospital Bichat; Nice France

10. Department of Dermatology; University Hospital of Besançon; Besançon France

11. Department of Dermatology; University Hospital of Nancy; Nancy France

12. Department of Oncology; Antoine Lacassagne Cancer Center; University of Nice-Sophia; Nice France

13. Laboratory of Clinical and Experimental Pathology and Human Biobank; Nice University Hospital; Nice France

14. Faculty of Medicine; INSERM 1081 Team 3 IRCAN; University of Nice Sophia Antipolis; Nice France

Funder

Institut National Du Cancer

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12576/fullpdf

Reference13 articles.

1. What's new in melanoma? Combination!;Ascierto;J. Transl. Med.,2015

2. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?;Ben Sahra;Mol. Cancer Ther.,2010

3. Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner;Cerezo;Mol. Cancer Ther.,2013

4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur. J. Cancer,2009

5. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review;Franciosi;PLoS One,2013

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Metformin Regulates the Proliferation and Motility of Melanoma Cells by Modulating the LINC00094/miR-1270 Axis;2024-07-29

3. Impact of metformin on melanoma: a meta-analysis and systematic review;Frontiers in Oncology;2024-05-23

4. Biguanide-PROTACs: Modulating Mitochondrial Proteins in Pancreatic Cancer Cells;2024-03-19

5. Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma;International Journal of Molecular Sciences;2024-01-31